Complaint Reporting. The project will complete and submit to the EPA details of complaints received and actions taken for resolution consistent with M4.5 of the EPL.
Complaint Reporting. All complaints shall be documented, maintained for three years, and made available for review by the State. All complaints pertaining to State-regulated sources shall be forwarded to the State no later than 5 working days from receipt of complaint, except for extraordinary circumstances. Complaint reporting shall include the name of the complainant (if known), complainant phone number (if provided), name of the source (if known), date of complaint, a description of the complaint and the action taken on the complaint.
Complaint Reporting. 1. Complaints reported directly to Miles will be summarized and forwarded to the Supervisor of Clinical Affairs at Schein. 2. All adverse drug experience complaints reported to Miles will be communicated to Schein within three working days of report receipt. Schein will be responsible for completion and submission to the Food and Drug Administration of Form FDA-3500A where appropriate . 3. Complaint reports which may meet NDA-Field Alert Report Criteria t21 CFR 314.81 (b) (1)] will be promptly communicated to Schein enabling FDA notification by Schein within three working days. Schein will advise Miles of NDA Field Alert Report submission and forward a copy of any such report to the Complaint Coordinator (see A.1 above) of Miles. B. Complaint Investigation:
Complaint Reporting. Unless otherwise noted in this Contract, DFPS will contact The SSCC when a complaint is received, and advise the SSCC whether DFPS will conduct an investigation or will coordinate with the SSCC for an investigation and a response. When DFPS requires the SSCC to conduct any part of the complaint investigation, The SSCC must respond in writing to DFPS with all information and according to DFPS requirements and specified time frames. If The SSCC is unwilling or unable to provide any information within the time required, The SSCC will provide a written explanation for any information that The SSCC does not submit, any applicable date by which The SSCC will provide the information, and the detailed reasons why The SSCC is unwilling or unable to provide such information.
Complaint Reporting. CPP shall have responsibility for reporting any complaints relating to Products to the Regulatory Authorities in the Territory, including, but not limited to, complaints relating to the manufacture of Products as well as adverse drug experience reports. At CPP’s request and upon reasonable notice, sanofi-aventis shall provide CPP with information and records in its possession or control concerning the manufacturing for such Product that is the subject of the complaint.
Complaint Reporting. Unless otherwise noted in this Contract, DFPS will contact Contractor when a complaint is received, and advise the Contractor whether DFPS will conduct an investigation or will coordinate with the Contractor for an investigation and a response. When DFPS requires the Contractor to conduct any part of the complaint investigation, Contractor must respond in writing to DFPS with all information and according to DFPS requirements and specified time frames. If Contractor is unwilling or unable to provide any information within the time required, Contractor will provide a written explanation for any information that Contractor does not submit, any applicable date by which Contractor will provide the information, and the detailed reasons why Contractor is unwilling or unable to provide such information.
Complaint Reporting. 1. Complaints reported directly to MGI will be forwarded to the Supervisor of Clinical Affairs at Schein; MGI may, at its option, forward summarized reports or reports in complete form. 2. All adverse drug experience complaints reported to MGI will be communicated to Schein within three working days of report receipt. Schein will be responsible for completion and submission to the Food and Drug Administration of Form FDA-3500A where appropriate. 3. Complaint reports which may meet NDA-Field Alert Report Xxxxxxxx [00 XXX 314.81(b)(1)] will be promptly communicated to Schein, enabling FDA notification by Schein within three working days. Schein will advise MGI of NDA Field Alert Report submission and forward a copy of any such report to the Complaint Coordinator (see A.1 above) of MGI.
Complaint Reporting. 1. Complaints reported directly to Bayer will be summarized, and forwarded immediately by fax to the Manager of Professional Affairs, or designee, at Schein. Bayer personnel will utilize and complete the Schein developed Drug Experience Report (DER) Form as per instructions when recording the adverse event/product complaint (Form attached.), or such other format as the parties may agree.
Complaint Reporting. Within thirty (30) days of NWI’ receipt of a lawsuit, complaint, charge, or grievance alleging a violation of Title III of the ADA, NWI will notify the United States in writing via e-mail at xxxxxx.xxxxxxxxxxx@xxxxx.xxx. The notification to the United States shall include the nature of the allegation, the name and contact information of the person(s) making the allegation, and NWI’s response. NWI shall reference this provision of the Agreement in its notification to the United States. NWI’s obligation to report such shall continue for the duration of the Agreement, and NWI shall maintain records of any complaints received for the duration of this Agreement.
Complaint Reporting. Unless otherwise noted in this Contract, DFPS will contact Grantee when a complaint is received, and advise the Grantee whether DFPS will conduct an investigation or will coordinate with the Grantee for an investigation and a response. When DFPS requires the Grantee to conduct any part of the complaint investigation, Xxxxxxx must respond in writing to DFPS with all information and according to DFPS requirements and specified time frames. If Grantee is unwilling or unable to provide any information within the time required, Grantee will provide a written explanation for any information that Grantee does not submit, any applicable date by which Grantee will provide the information, and the detailed reasons why Grantee is unwilling or unable to provide such information.
